Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
785 Views
eMediNexus 11 January 2018
Results from the ADMIRE CD trial published online December 22, 2017 in the journal Gastroenterology have shown resolution of treatment-refractory complex perianal fistulas at one year with local stem cell therapy with allogeneic expanded adipose-derived stem cells (Cx601) in patients with Crohns disease.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}